Dr. Homam Alkaied
Claim this profileSaint Luke's Hospital of Duluth
Studies Lung Cancer
Studies Cancer
15 reported clinical trials
27 drugs studied
Area of expertise
1Lung Cancer
Stage II
Stage I
Stage III
2Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Homam Alkaied is currently running
Atezolizumab + Chemotherapy
for Neuroendocrine Carcinoma
This trial is testing a new treatment combining an immune-boosting drug with standard chemotherapy for patients with a specific type of aggressive cancer that has spread. The goal is to help the immune system fight the cancer and use chemotherapy to kill cancer cells.
Recruiting1 award Phase 2 & 310 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint High 2 Risk (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint High 2 Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
More about Homam Alkaied
Clinical Trial Related3 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Homam Alkaied has experience with
- Biospecimen Collection
- Atezolizumab
- Pembrolizumab
- Carboplatin
- Etoposide
- Cisplatin
Breakdown of trials Homam Alkaied has run
Lung Cancer
Cancer
Breast Cancer
Breast cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Homam Alkaied specialize in?
Homam Alkaied focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Homam Alkaied currently recruiting for clinical trials?
Yes, Homam Alkaied is currently recruiting for 8 clinical trials in Duluth Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Homam Alkaied has studied deeply?
Yes, Homam Alkaied has studied treatments such as Biospecimen Collection, Atezolizumab, Pembrolizumab.
What is the best way to schedule an appointment with Homam Alkaied?
Apply for one of the trials that Homam Alkaied is conducting.
What is the office address of Homam Alkaied?
The office of Homam Alkaied is located at: Saint Luke's Hospital of Duluth, Duluth, Minnesota 55805 United States. This is the address for their practice at the Saint Luke's Hospital of Duluth.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.